Nut allergy is an important and potentially life threatening food allergy with a prevalence of one in
Introduction
Nut allergy is a common food allergy and usually has an early onset in childhood. It is frequently persistent and life threatening due to the risk of anaphylactic shock. 1 Almost 8% of children experience food allergy in the first 3 years of life. 2 According to population studies in the UK the prevalence of peanut and/or tree nut allergy has been estimated as being one in 150 children 1, 3 and is the cause of most fatal and near-fatal allergic reactions. 4 The persistent and severe nature of nut allergy and also the difficulty in avoiding nuts or nut products in foods through accidental ingestion followed by a potentially fatal reaction attracts attention to this type of allergy as an important clinical problem.
TH2 type cytokines especially IL-4 have a major role in the induction and triggering of the allergic response. 5 Although environmental factors are likely to play an important role in the development and specificity of an allergic response, genetic factors also have been shown to be important. 6 A region on chromosome 12q has been shown to be linked with total serum IgE concentration and atopy in several different populations.
pathway used by IL-4 and IL-13 in IgE isotype switching and production of TH2 cytokines. [10] [11] [12] In STAT6-deficient mice it has been observed that most IL-4-mediated functions are reduced. 10 Furthermore a study by Miyata et al 13 in STAT6-deficient mice demonstrated an absence of eosinophilia and lung damage as a consequence of aeroallergen challenge. STAT6 also regulates the production of TH2-type cytokines by both CD4 + and CD8 + T cells, further indicating an important role of STAT6 in allergic responses. 13 It is assumed that IL-13, which has similar biological activities to IL-4, can also account for the development of an allergic response in the absence of IL-4 in the same pathway, using STAT6 activation. 14 The STAT6 gene has been mapped to chromosome 12q. 15 We have recently identified a single nucleotide polymorphism (SNP) in the 3ЈUTR region of the STAT6 gene 16 and reported allele and genotype frequencies of this polymorphism in a healthy UK population. In this study we examined the hypothesis that STAT6 gene polymorphism may contribute risk for the development of nut allergy. Table 2 .
Results

Patients characteristics
STAT6 genotype frequencies in nut allergy patients and control groups
The STAT6 G allele frequency was significantly increased in the nut allergy patients compared with blood donor controls (87% vs 69%, P Ͻ 0.0001, OR = 2.9, 95% CI: 1.7-4.9) ( Table 3 ). STAT6 GG homozygosity was also significantly increased in these patients compared with controls using a recessive model (GG vs GA+AA, P = 0.0001, OR = 3.2, 95% CI: 1.7-5.8). Unfortunately no information was available regarding the atopic status of these controls and previous studies suggest that the prevalence of allergy to environmental allergens may be considerable. 17 This suggest that using such controls would make it more difficult to demonstrate a genetic association with atopy and any association found is likely to be an underesti- Scores have been given based on measurement of 2 mm greater than the positive control for SPT and 2 units above the standard unit for RAST test.
Genes and Immunity mate of the true underlying relationship. The frequency of the G allele (76%) and GG homozygotes (58%) in atopic patients without nut allergy were increased compared with blood donor controls (69% and 48% respectively) but these differences did not achieve a level of statistical significance.
STAT6 genotype frequencies in severe nut allergy cases
The nut allergy patients were divided to severe, moderate and mild cases according to their reported reactions after the ingestion of nuts. The majority of cases in our cohort (65%) had previously experienced a severe reaction. The G allele was most frequent in the severe group (Table 4) and GG homozygosity was associated with the highest risk for a severe reaction (OR = 3.9, 95% CI: 1.9-8.3). The STAT6 GG genotype was less associated with mild/moderate reactions (P = 0.05, OR = 2.3, 95% CI: 1.0-5.5).
Total and specific serum IgE level association with STAT6 polymorphism in different populations
There was no significant difference in mean total or specific IgE level in patients with the GG genotype compared with to those with other genotypes. When nut allergy and atopic patients were combined a small increase in median total serum IgE level was observed in patients carrying the GG genotype compared to patients carrying either GA or AA genotype but this did not reach a level of significance using the Mann-Whitney test (262 vs 196 units respectively, P = 0.4).
Discussion
In this study we have examined whether genetic polymorphism in the STAT6 gene is associated with nut allergy. Our results suggest that presence of the STAT6 3ЈUTR G allele is significantly associated with increased risk of nut allergy.
The GG homozygous genotype conveys the highest risk and this suggests that the G allele may act in an additive or recessive way. As yet it is not known whether the STAT6 polymorphism described is of functional consequence and whether it directly effects gene expression. Previous studies have demonstrated that polymorphisms within the 3ЈUTR region of genes can influence mRNA stability and in consequence effect the level of protein production. 18 It is not possible yet to conclude that the STAT6 polymorphisms described is directly responsible for the association of this gene with nut allergy. The association of STAT6 with nut allergy could be due to linkage disequilibrium of this SNP with another polymorphism in the coding region or promoter region of the STAT6 gene or another gene in close physical proximity.
Although a significant association was observed between STAT6 polymorphism and nut allergy it is unlikely that this represents a specific association with this condition. Indeed although non-significant increase in the STAT6 G allele frequency was observed in the atopic patients without nut allergy, this was at an intermediate level between the nut allergy group and blood donor controls. This is likely to be explained by the STAT6 G allele being associated with severity of allergy. A large proportion of the nut allergy cases had either a history of severe reaction or anaphylaxis. In contrast atopic patients without nut allergy had been identified from healthy volunteers who exhibited asthma, eczema or hay fever. Consequently the majority of these did not exhibit severe atopic reaction.
STAT6 maps to a region on chromosome 12q, which has been previously linked with total serum IgE concentration and atopy in several different populations. [7] [8] [9] IgE antibodies are largely responsible for triggering type 1 immediate-hypersensitivity reactions. In studies of food allergy there is little data relating clinical severity and IgE level. 19 In study by Clarke et al 20 serum levels of IgE to a 15 kDa protein has been shown to be significantly higher in peanut allergy patients experiencing severe symptoms than those classified as having a moderate or mild reaction. In our study there was no obvious association between the levels of total or specific serum IgE and STAT6 GG genotype in nut allergy patients. However when the data relating to total serum IgE levels were pooled for nut allergy and atopic patients, a small but not significant increase in level was observed in the GG homozygotes. Given the normal variability that exists day to day in atopic patients it is likely that a much larger group of patients will need to be examined before a categorical conclusion can be drawn.
Although the effect of STAT6 polymorphism appears to be highly significant (P Ͻ 0.0001, for the allele frequency), it is unlikely to account for the major genetic component to this condition. However this association is compatible with nut allergy having a complex aetiology where both environmental and oligogenic factors contribute. It is likely that the aetiology of nut allergy has several discrete components to its development and that genetic factors could contribute to each stage. An obvious component comprises the specificity of the initiating response to the allergens. Dorion and Leung 21 have proposed that restricted use of the V␤ 2 T cell receptor (TCR) may account, for the severity of the immune response to peanut allergens. Moffatt et al 22 have also described an association between T-cell receptor ␣/␦ complex and specific IgE responses to the dust mite allergen but no linkage was found with the ␤ chain.
Linkage and association studies of atopy and allergy have already identified a number of chromosomal areas. 6, 23 Genes, which are important in the specificity and recognition of allergens, represent good candidates for susceptibility factors. This is supported by markers within the HLA region on chromosome 6 and within the TCR gene complex on chromosome 14q11, which show significant linkage with atopy. 6, 23 Previous studies have provided evidence for association between susceptibility to allergy (with or without asthma-related symptoms), and HLA-DR4 and/or the DR7 allele. 24 Howell et al 25 have also demonstrated significant increase in HLA-DRB1*08, and the DQB1*04 allele in peanut allergy patients. A region in chromosome 5, which contains a cluster of cytokines, IL-4, IL-13, IL-9 and GM-CSF, has also been considered as being an important locus in regulating the allergic response. A divergent association between SNP's in promoter region of the genes within this region has been observed in different atopic patient populations. 26 A marker has been found on chromosome 11q13 which has been strongly linked with atopy and total serum IgE level and shows a maternal effect. The association between the Fc ⑀ R1 polymorphisms in this region with atopy was also divergent in patients from different ethnic groups. 27 Environmental factors are another major component in the development of atopy in different populations. A large increase in the prevalence of atopic disease in the western countries is striking and a rural lifestyle has been shown to be protective both in Europe and Africa. 28 It is assumed that the differences in the nature of childhood infection or bacterial flora of the bowel are responsible for these patterns. 28 The specificity of antigen also seems to be important in the development and also severity of clinical reaction. Several proteins in the nut kernel have been identified as being allergenic. These include the major storage proteins arachin and conarachin, peanut lectin and phospholipase D, the acidic glycoprotein, peanut 1 and three major allergens, which have been characterised and sequenced as Ara h1, 2 and 3. 20 Current in vitro tests cannot distinguish between patients experiencing mild or severe nut allergic reactions, or predict the likely event of a likely further severe reaction. Given that the STAT6 homozygous GG genotype is associated with a more severe phenotype it may be possible that such information, when combined with other genetic and laboratory data, could help predict the risk of subsequent severe reactions. Such an approach could be of clinical use.
Methods
Population studied
Seventy-one unrelated Caucasians nut allergic patients were recruited for this study from the Allergy Clinic at Llandough Hospital, Cardiff. All patients who had had positive SPT to peanut, cashew, brazil nut, pecan, almond, hazelnut or walnut since 1993 were asked to attend. Out of 83 patients recruited, a total of 12 were excluded: five because they were related to nut allergic patients already in the study and seven because they gave a poor history of nut allergy despite being SPT positive. The remaining 71 (mean age: 10 ± 12.1 years at onset) were analysed in the study. Forty-five healthy volunteers from hospital and university staff with a history of asthma, eczema or hay fever were recruited as atopic controls. All were SPT negative to nuts and SPT positive for one of the common allergens (house dust mite, cat dander, grass pollen). A total of 184 UK Caucasoid blood donors were also available for comparison. No information regarding atopic status was available on this group. Ethical approval was obtained for this study and all cases and controls gave informed consent.
Symptom severity
Nut allergy symptoms were graded using a modification of the system of Clarke et al. 20 These were as follows: mild (vomiting, abdominal pain, irritability, pruritus and/or urticaria), moderate (facial oedema including lip and mouth swelling), severe (laryngeal oedema, cyanosis, wheeze and collapse or anaphylaxis).
Genotyping of the STAT6 polymorphism
The genotyping of the samples were carried out using the method has been described previously.
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Statistical analysis Continuous data were described as median, mean, and standard deviation (mean ± s.d.), and categorical variables as percentages. Strength of association was estimated using odds ratios (OR) and by calculating 95% confidence intervals (CI). Levels of significance were determined by chi-square analysis. The Mann-Whitney test was used to assess phenotypic differences between carriers of different genotypes. Analyses were carried out using the STATAV6 software package and SPSS v9.
